ARES AK – Dermo Restructuring (4 x 4ml) Mesotherapy
ARES
Mesotherapy skin boosterInjectable dermo-restructuring bio-stimulator
Certifications
- Hyaluronic acid component used in the ARES mesotherapy line is described by manufacturer and selected distributors as CE Marked and FDA Certified for injectable use.
- Professional mesotherapy product intended to be used in accordance with EU medical device and local regulatory requirements.
- Protocols reference use with CE or FDA Certified microneedling and electroporation devices as part of treatment delivery.
- Hyaluronic acid component used in the ARES mesotherapy line is described by manufacturer and selected distributors as CE Marked and FDA Certified for injectable use.
- Professional mesotherapy product intended to be used in accordance with EU medical device and local regulatory requirements.
- Protocols reference use with CE or FDA Certified microneedling and electroporation devices as part of treatment delivery.
Injectable dermo-restructuring bio-stimulator
Description
ARES AK – Dermo Restructuring is a professional mesotherapy skin booster developed by CMed Aesthetics, the creators of BioRePeel. It is a dermo-restructuring bio-stimulator formulated with succinic acid, a pool of 14 natural amino acids, and high and low molecular weight hyaluronic acids (84 mg) to support cellular metabolism, collagen synthesis, deep hydration and tissue repair. Indicated for tired, dull and scarred skin, it targets fine lines, wrinkles and various types of tissue scarring, including acne-related damage and sun-induced changes. The product is intended for use by trained medical aesthetic professionals via injectable mesotherapy techniques (microinjections and/or microneedling) to improve firmness, elasticity, texture and overall skin quality over a series of treatments.
Bnefits
- Stimulates metabolic processes in the dermis via succinic acid, promoting skin rejuvenation and dermal restructuring
- Improves skin firmness and elasticity by supporting collagen and extracellular matrix synthesis
- Provides intense and long-lasting hydration with high and low molecular weight hyaluronic acids (total 84 mg)
- Helps reduce the appearance of acne scars and other tissue scarring (e.g. trauma and sun damage)
- Softens fine lines and wrinkles on the forehead, periorbital area and glabellar region
- Revitalises tired, dull and photo-damaged skin, restoring brightness and healthier tone
- Supports tissue repair and overall skin health through a blend of 14 natural amino acids
- Can be combined with BioRePeelCl3 and other ARES mesotherapy cocktails as part of advanced aesthetic protocols
- Designed for minimal downtime when performed correctly by trained professionals
Indications
- Tired-looking, dull skin
- Fine lines and wrinkles (forehead lines, frown lines, crow’s feet)
- Loss of firmness and elasticity
- Acne scarring
- Other tissue scarring (e.g. post-traumatic or post-surgical scars, sun damage)
- Age-related skin imperfections and texture irregularities
- Photo-damage and uneven skin tone
- Adjunctive treatment in comprehensive facial rejuvenation protocols
Composition
- Succinic acid (dermo-restructuring metabolic stimulator)
- Blend of 14 natural amino acids supporting collagen synthesis and tissue repair
- High molecular weight hyaluronic acid for surface hydration and plumping
- Low molecular weight hyaluronic acid for deeper hydration and bio-stimulation
- Total hyaluronic acid content per vial: 84 mg (non-crosslinked, injectable hydrogel base)
Formulation
- Sterile, pyrogen-free injectable mesotherapy solution
- Non-crosslinked hyaluronic acid hydrogel containing succinic acid and amino acids
- Intended for intradermal / superficial injection and/or microneedling-assisted delivery
- Single-patient use vials
Packaging
- Box containing 4 glass vials x 4 ml each (total 16 ml)
- Individually sealed vials for single-patient, single-treatment session use as per clinic protocol
- Professional-only product supplied via authorised medical aesthetic distributors
Usage
- Professional-use only: ARES AK must be used exclusively by trained medical aesthetic practitioners in an appropriate clinical setting.
- Patient assessment: Take a full medical history including allergies, medications, previous aesthetic procedures and any relevant skin or systemic conditions.
- Skin preparation: Cleanse and degrease the treatment area, then disinfect according to clinic protocol (e.g. chlorhexidine, iodine or benzalkonium chloride), avoiding contact with eyes and mucosa.
- Technique options: Administer via superficial intradermal microinjections, mesotherapy nappage, or microneedling / transdermal mesotherapy using a CE- or FDA-certified device, according to the indication and protocol.
- Volume per session: Typically 1.5–2.0 ml of ARES AK per treatment area, adjusting volume based on surface area, skin condition and clinical judgement.
- Microneedling protocol (if used): Microneedle the area according to the main concern (depth generally ranging from superficial to moderate), apply 1.5–2.0 ml of ARES AK to the treated zone, then repeat microneedling passes to enhance penetration.
- Treatment course: Common mesotherapy protocols recommend 4–5 sessions spaced approximately every 2–4 weeks for superficial procedures and every 4–6 weeks for deeper procedures, with 2–3 series per year depending on clinical need.
- Post-treatment care: Allow several minutes for product absorption, gently remove any excess with sterile gauze and apply post-procedure skincare as per clinic protocol (e.g. BioReHydra/BioReLift and broad-spectrum SPF 50).
- Combination therapy: May be combined in protocols with BioRePeelCl3 and other ARES cocktails (AO, AA, HB) as per official guidance and practitioner experience.
- Safety: Do not use in patients with known hypersensitivity to any component. Avoid injection into inflamed, infected or compromised skin and follow all local regulations and official IFU instructions.
Contraindications
- Use by non-medical or untrained personnel (professional-use-only injectable product)
- Known or suspected hypersensitivity or allergy to hyaluronic acid, succinic acid, amino acids or any excipients in the formulation
- Active skin infection, inflammation or disease at the intended treatment site (e.g. herpes simplex, bacterial or fungal infections)
- General contraindications to injectable mesotherapy as outlined in the official instructions for use (IFU) and local regulations
Adverse Effects
- No specific adverse event profile is detailed in publicly available marketing materials; however, as with other injectable mesotherapy and hyaluronic acid procedures, potential reactions may include temporary erythema, swelling, tenderness, bruising, mild pain at injection sites and, rarely, more serious complications.
- Practitioners should consult the official product IFU and follow local clinical guidelines for full risk information and management of potential complications.
Storage Conditions
- Specific storage conditions are not fully detailed in publicly accessible marketing summaries.
- Clinics should follow the storage instructions on the original packaging and IFU, which typically include storing in a cool, dry place away from excessive heat and direct light, not freezing the product and keeping vials in their original carton until use.
- Keep out of reach of unauthorised persons and patients; for professional use only.
Duration
Clinical product information from distributors states that improvements in skin firmness, elasticity and texture can last for several months after a course of treatments, with maintenance or touch-up sessions generally recommended every 4 to 6 months depending on individual skin condition and ageing pattern.
Onset
Manufacturer and distributor literature does not specify an exact onset time; results are described as progressive, with visible improvements typically developing gradually over a series of 4\u20135 treatment sessions performed at 2\u20134 week intervals.
